Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

L.A. McKeown

October 14, 2025

News Daily News

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

L.A. McKeown

January 02, 2024

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Caitlin E. Cox

October 20, 2022

News Daily News

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

Michael O'Riordan

October 17, 2022

News Daily News

Steep Rise in PVAD Support for Protected PCI: Medicare Data

Caitlin E. Cox

August 19, 2022

News Daily News

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Caitlin E. Cox

July 20, 2022

News Daily News

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

Caitlin E. Cox

November 24, 2021

News Daily News

MitraClip Viable in Shock Patients With Significant MR: Observational Study

Michael O'Riordan

July 29, 2021

News Daily News

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

Caitlin E. Cox

July 06, 2021

News Daily News

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Caitlin E. Cox

November 06, 2019

News Daily News

Study Finds Exponential Growth in Percutaneous LVAD Use

April 08, 2015

News Daily News

Mortality, Hospital Costs Drop as Short-term Mechanical Circulatory Support Use Grows

November 02, 2014

Advertisement

Percutaneous LVADs Can Spur Aortic Regurgitation, Small Study Cautions

Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Many STEMI Patients Not Treated Within National Time Goals

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

Steep Rise in PVAD Support for Protected PCI: Medicare Data

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Shock in COVID-19: Types, Triggers, and Treatments Differ, but Outlook Is Grim

MitraClip Viable in Shock Patients With Significant MR: Observational Study

Fivefold Increase in Impella Use for Cardiogenic Shock in Acute MI: US Data

For Percutaneous LVADs, Vascular Complications Decreasing but Still Common

Study Finds Exponential Growth in Percutaneous LVAD Use

Mortality, Hospital Costs Drop as Short-term Mechanical Circulatory Support Use Grows

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content